PRESS RELEASE
Published August 9, 2023
The Global Acute Respiratory Distress Syndrome (ARDS) Market is poised to register a CAGR of 10.2% during the forecast period 2023 to 2031.
Table of Contents
Acute Respiratory Distress Syndrome (ARDS) Market Introduction
Acute Respiratory Distress Syndrome (ARDS) is a fatal condition that affects the lungs. It is a type of respiratory failure characterized by the rapid onset of severe breathing difficulty, low levels of oxygen in the blood, and widespread inflammation in the lungs. ARDS can occur as a complication of various underlying conditions such as pneumonia, sepsis, trauma, or inhalation injuries. Symptoms of ARDS typically include shortness of breath, low oxygen levels in the blood, rapid breathing, and chest discomfort. It is a critical condition which requires immediate medical attention and intensive care management, including mechanical ventilation and supportive therapies. The mortality rate of ARDS remains high, despite advances in medical technology and treatment options.
FutureWise Market Research has published a report that provides an insightful analysis of Acute Respiratory Distress Syndrome (ARDS) Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
By the end of the forecast period FutureWise research analysts projects that Acute Respiratory Distress Syndrome (ARDS) Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
Acute Respiratory Distress Syndrome (ARDS) Market Segmentation:
By Drug Class
• Vasoconstrictors
• Bronchodilators
• Steroids and Antibiotics
• Nitric Oxide
• Sedatives & Paralytics
• Surfactant
• Others
By Route of Administration
• Oral
• Injection
• Inhalation
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.
Get a Sample of the Acute Respiratory Distress Syndrome (ARDS) Market Report @
www.futurewiseresearch.com/healthcare-market-research/Acute-Respiratory-Distress/11046
Major players included in the Acute Respiratory Distress Syndrome (ARDS) Market:
• Atersys Inc
• MondoBIOTECh AG
• HEALIOS K.K.
• GlaxoSmithKline Plc
• Pfizer Inc
• Teva Pharmaceuticals
• Altor bioScience
• Faron Pharmaceuticals
Recent developments by key players in Acute Respiratory Distress Syndrome (ARDS) Market:
In April 2022, A landmark Phase 3 clinical research employing Direct Biologics' investigational EV drug ExoFlow to treat Acute Respiratory Distress Syndrome (ARDS) was given FDA approval.
Drivers of Acute Respiratory Distress Syndrome (ARDS) Market
Increase prevalence of respiratory ailments
The increasing prevalence of respiratory disorders is a major driver of the ARDS market. Respiratory diseases such as pneumonia, sepsis, COVID-19, and other respiratory infections are common underlying conditions that can lead to the development of ARDS. As the incidence of these conditions continues to rise, the demand for effective treatments for ARDS will also increase. For example, the COVID-19 pandemic has caused an increase in the number of patients with severe respiratory symptoms, leading to an increased incidence of ARDS. This has put a significant strain on healthcare systems worldwide, highlighting the need for effective treatments for ARDS. Due to the increase prevalence of disease. the market for Acute Respiratory Distress Syndrome (ARDS) is expected to rise.
Restraint of Acute Respiratory Distress Syndrome (ARDS) Market
Lack of specific therapies
ARDS is a complex condition that involves multiple pathways and mechanisms, making it difficult to develop targeted therapies. Most current treatments for ARDS are supportive measures to manage symptoms and prevent complications. This includes mechanical ventilation, oxygen therapy, and medications to improve oxygenation and reduce inflammation. The lack of specific therapies for ARDS presents a significant challenge for healthcare professionals and researchers. Without effective targeted therapies, the management of ARDS remains largely supportive, with limited options for improving outcomes and reducing mortality rates which is causing hinderance to the market growth.
Opportunity of Acute Respiratory Distress Syndrome (ARDS) Market
Cell-based therapies for ARDS
There is a rising interest in the use of cell-based therapies, such as stem cells and mesenchymal stromal cells (MSCs), as a potential treatment for ARDS. Preclinical studies and early-phase clinical trials have shown promising results, suggesting that these therapies may improve lung function and reduce inflammation in patients with ARDS. MSCs have been shown to have an anti-inflammatory and immunomodulatory effects, which may be beneficial in treating ARDS. While the use of cell-based therapies for ARDS is currently in its early phases of development, there is significant interest and investment in this area. Further research is required to thoroughly comprehend the safety and efficacy of these therapies and identify the optimal dose and route of administration. If successful, cell-based therapies could represent a significant opportunity for the treatment of ARDS, providing a targeted and potentially curative approach to this serious medical condition.
FutureWise Insights: According to FutureWise analysis, the market for Acute Respiratory Distress Syndrome (ARDS) is expected to grow at a CAGR of 10.2% over the forecast period of 2023-2031.
Objectives of Study:
To provide with an exhaustive analysis on the Acute Respiratory Distress Syndrome (ARDS) Market By Drug Class, By Route of Administration, By Distribution Channel and By Region
To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches
Key Takeaways: FutureWise research report will help you understand the growth prospects, key trends, and data points affecting the market's growth. A detailed review of strategies being opted by the players in this market, and a thorough market share registered by the key companies globally as well as on a regional basis.
Delivery model: You can reach us directly at [email protected]. We offer a flexible delivery model wherein you can request changes in the scope/table of content as per your requirements. Customized Mobility Care is free of charge associated with any license purchase of any report.
Table of Contents:
Market Introduction
Research Methodology
Executive Summary
Market Variables, Trends, and Scope
Market Overview
Market Analysis Tools
Market Segmentation
Regional Landscape
Market Share Analysis and Competitive Landscape
Company Profiles
Impact of COVID-19
Impact of Russia-Ukraine War
Competitive Intelligence and Competitive Matrix
Major Deals and Strategic Alliances Analysis
Relevant Case Studies and Latest News Updates
Key Takeaway Points from the Analysts at FutureWise Market Research
Frequently Asked Questions:
What are the Acute Respiratory Distress Syndrome (ARDS) Market’s revenue, sales, and pricing analysis for the top manufacturers globally and based on region?
Which key factors are driving market growth?
What is the historic and forecast CAGR of market?
Which country holds the greater percentage share of market globally?
What current factors are creating opportunities for vendors in this market?
What challenges are being faced by new market entrants in this industry?
How is Russia-Ukraine War impacting the overall growth of this market?
About & Contact Details:
We specialize in high-growth niche “Healthcare” market research, and offer flexibility, agility, as well as tailored solutions & services for our clients. Our research is based on both primary and secondary methods, wherein primary consists of opinions, interviews of key opinion leaders, and high ranked doctors specializing in a particular field of medicine. Our market insights and consulting services enable our clients to stay ahead of their industries for many years.
FutureWise Market Research
Vinay T - Head of Business Development
Email: [email protected]
UK: +44 141 628 9353 | USA: +1 347 709 4931
Website: www.futurewiseresearch.com
